Report cover image

Global MMR Vaccines Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 193 Pages
SKU # APRC20556589

Description

Summary

According to APO Research, the global MMR Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for MMR Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for MMR Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the MMR Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for MMR Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the MMR Vaccines market include Merck, GlaxoSmithKline, Serum Institute, Sanofi Pasteur and Medlmmune, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for MMR Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of MMR Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for MMR Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the MMR Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global MMR Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for MMR Vaccines sales, projected growth trends, production technology, application and end-user industry.

MMR Vaccines Segment by Company

Merck
GlaxoSmithKline
Serum Institute
Sanofi Pasteur
Medlmmune
MMR Vaccines Segment by Type

Combinational
Monovalent
Trivalent
Divalent
MMR Vaccines Segment by Application

Adolescents
Elderly
Pediatrics
Adults
MMR Vaccines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global MMR Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions MMR Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify MMR Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze MMR Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MMR Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of MMR Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MMR Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the MMR Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global MMR Vaccines industry.
Chapter 3: Detailed analysis of MMR Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of MMR Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of MMR Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global MMR Vaccines Sales Value (2020-2031)
1.2.2 Global MMR Vaccines Sales Volume (2020-2031)
1.2.3 Global MMR Vaccines Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 MMR Vaccines Market Dynamics
2.1 MMR Vaccines Industry Trends
2.2 MMR Vaccines Industry Drivers
2.3 MMR Vaccines Industry Opportunities and Challenges
2.4 MMR Vaccines Industry Restraints
3 MMR Vaccines Market by Company
3.1 Global MMR Vaccines Company Revenue Ranking in 2024
3.2 Global MMR Vaccines Revenue by Company (2020-2025)
3.3 Global MMR Vaccines Sales Volume by Company (2020-2025)
3.4 Global MMR Vaccines Average Price by Company (2020-2025)
3.5 Global MMR Vaccines Company Ranking (2023-2025)
3.6 Global MMR Vaccines Company Manufacturing Base and Headquarters
3.7 Global MMR Vaccines Company Product Type and Application
3.8 Global MMR Vaccines Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global MMR Vaccines Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 MMR Vaccines Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 MMR Vaccines Market by Type
4.1 MMR Vaccines Type Introduction
4.1.1 Combinational
4.1.2 Monovalent
4.1.3 Trivalent
4.1.4 Divalent
4.2 Global MMR Vaccines Sales Volume by Type
4.2.1 Global MMR Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global MMR Vaccines Sales Volume by Type (2020-2031)
4.2.3 Global MMR Vaccines Sales Volume Share by Type (2020-2031)
4.3 Global MMR Vaccines Sales Value by Type
4.3.1 Global MMR Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global MMR Vaccines Sales Value by Type (2020-2031)
4.3.3 Global MMR Vaccines Sales Value Share by Type (2020-2031)
5 MMR Vaccines Market by Application
5.1 MMR Vaccines Application Introduction
5.1.1 Adolescents
5.1.2 Elderly
5.1.3 Pediatrics
5.1.4 Adults
5.2 Global MMR Vaccines Sales Volume by Application
5.2.1 Global MMR Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global MMR Vaccines Sales Volume by Application (2020-2031)
5.2.3 Global MMR Vaccines Sales Volume Share by Application (2020-2031)
5.3 Global MMR Vaccines Sales Value by Application
5.3.1 Global MMR Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global MMR Vaccines Sales Value by Application (2020-2031)
5.3.3 Global MMR Vaccines Sales Value Share by Application (2020-2031)
6 MMR Vaccines Regional Sales and Value Analysis
6.1 Global MMR Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global MMR Vaccines Sales by Region (2020-2031)
6.2.1 Global MMR Vaccines Sales by Region: 2020-2025
6.2.2 Global MMR Vaccines Sales by Region (2026-2031)
6.3 Global MMR Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global MMR Vaccines Sales Value by Region (2020-2031)
6.4.1 Global MMR Vaccines Sales Value by Region: 2020-2025
6.4.2 Global MMR Vaccines Sales Value by Region (2026-2031)
6.5 Global MMR Vaccines Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America MMR Vaccines Sales Value (2020-2031)
6.6.2 North America MMR Vaccines Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe MMR Vaccines Sales Value (2020-2031)
6.7.2 Europe MMR Vaccines Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific MMR Vaccines Sales Value (2020-2031)
6.8.2 Asia-Pacific MMR Vaccines Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America MMR Vaccines Sales Value (2020-2031)
6.9.2 South America MMR Vaccines Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa MMR Vaccines Sales Value (2020-2031)
6.10.2 Middle East & Africa MMR Vaccines Sales Value Share by Country, 2024 VS 2031
7 MMR Vaccines Country-level Sales and Value Analysis
7.1 Global MMR Vaccines Sales by Country: 2020 VS 2024 VS 2031
7.2 Global MMR Vaccines Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global MMR Vaccines Sales by Country (2020-2031)
7.3.1 Global MMR Vaccines Sales by Country (2020-2025)
7.3.2 Global MMR Vaccines Sales by Country (2026-2031)
7.4 Global MMR Vaccines Sales Value by Country (2020-2031)
7.4.1 Global MMR Vaccines Sales Value by Country (2020-2025)
7.4.2 Global MMR Vaccines Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA MMR Vaccines Sales Value Growth Rate (2020-2031)
7.5.2 USA MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.5.3 USA MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada MMR Vaccines Sales Value Growth Rate (2020-2031)
7.6.2 Canada MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico MMR Vaccines Sales Value Growth Rate (2020-2031)
7.6.2 Mexico MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany MMR Vaccines Sales Value Growth Rate (2020-2031)
7.8.2 Germany MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France MMR Vaccines Sales Value Growth Rate (2020-2031)
7.9.2 France MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.9.3 France MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. MMR Vaccines Sales Value Growth Rate (2020-2031)
7.10.2 U.K. MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy MMR Vaccines Sales Value Growth Rate (2020-2031)
7.11.2 Italy MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain MMR Vaccines Sales Value Growth Rate (2020-2031)
7.12.2 Spain MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia MMR Vaccines Sales Value Growth Rate (2020-2031)
7.13.2 Russia MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands MMR Vaccines Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries MMR Vaccines Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China MMR Vaccines Sales Value Growth Rate (2020-2031)
7.16.2 China MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.16.3 China MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan MMR Vaccines Sales Value Growth Rate (2020-2031)
7.17.2 Japan MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea MMR Vaccines Sales Value Growth Rate (2020-2031)
7.18.2 South Korea MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India MMR Vaccines Sales Value Growth Rate (2020-2031)
7.19.2 India MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.19.3 India MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia MMR Vaccines Sales Value Growth Rate (2020-2031)
7.20.2 Australia MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia MMR Vaccines Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil MMR Vaccines Sales Value Growth Rate (2020-2031)
7.22.2 Brazil MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina MMR Vaccines Sales Value Growth Rate (2020-2031)
7.23.2 Argentina MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile MMR Vaccines Sales Value Growth Rate (2020-2031)
7.24.2 Chile MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia MMR Vaccines Sales Value Growth Rate (2020-2031)
7.25.2 Colombia MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru MMR Vaccines Sales Value Growth Rate (2020-2031)
7.26.2 Peru MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia MMR Vaccines Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel MMR Vaccines Sales Value Growth Rate (2020-2031)
7.28.2 Israel MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE MMR Vaccines Sales Value Growth Rate (2020-2031)
7.29.2 UAE MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey MMR Vaccines Sales Value Growth Rate (2020-2031)
7.30.2 Turkey MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran MMR Vaccines Sales Value Growth Rate (2020-2031)
7.31.2 Iran MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran MMR Vaccines Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt MMR Vaccines Sales Value Growth Rate (2020-2031)
7.32.2 Egypt MMR Vaccines Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt MMR Vaccines Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck MMR Vaccines Sales, Value and Gross Margin (2020-2025)
8.1.4 Merck MMR Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Comapny Information
8.2.2 GlaxoSmithKline Business Overview
8.2.3 GlaxoSmithKline MMR Vaccines Sales, Value and Gross Margin (2020-2025)
8.2.4 GlaxoSmithKline MMR Vaccines Product Portfolio
8.2.5 GlaxoSmithKline Recent Developments
8.3 Serum Institute
8.3.1 Serum Institute Comapny Information
8.3.2 Serum Institute Business Overview
8.3.3 Serum Institute MMR Vaccines Sales, Value and Gross Margin (2020-2025)
8.3.4 Serum Institute MMR Vaccines Product Portfolio
8.3.5 Serum Institute Recent Developments
8.4 Sanofi Pasteur
8.4.1 Sanofi Pasteur Comapny Information
8.4.2 Sanofi Pasteur Business Overview
8.4.3 Sanofi Pasteur MMR Vaccines Sales, Value and Gross Margin (2020-2025)
8.4.4 Sanofi Pasteur MMR Vaccines Product Portfolio
8.4.5 Sanofi Pasteur Recent Developments
8.5 Medlmmune
8.5.1 Medlmmune Comapny Information
8.5.2 Medlmmune Business Overview
8.5.3 Medlmmune MMR Vaccines Sales, Value and Gross Margin (2020-2025)
8.5.4 Medlmmune MMR Vaccines Product Portfolio
8.5.5 Medlmmune Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 MMR Vaccines Value Chain Analysis
9.1.1 MMR Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 MMR Vaccines Sales Mode & Process
9.2 MMR Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 MMR Vaccines Distributors
9.2.3 MMR Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.